Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/INMED-PHARMACEUTICALS-INC-18407562/news/InMed-Announces-Presentation-of-INM-755-Phase-2-Clinical-Study-Results-at-12th-World-Congress-on-Itc-45223684/?utm_source=whatsapp&utm_medium=social&utm_campaign=share